Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Advances in Diabetes Management and Technology
This week's episode covers the latest in diabetes research, from nephropathy classification to cutting-edge technology and pharmacotherapy advances, featuring key studies from leading researchers in the field.
Bibliography
1. Classification and Differential Diagnosis of Diabetic Nephropathy.
Authors: Qi C, Mao X, Zhang Z, et al.
Journal: Journal of diabetes research, 2017
PMID: 28316995
DOI: 10.1155/2017/8637138
2. Virtual care for young adults with type 1 diabetes: a 12-month follow-up of a wait-list randomized controlled trial.
Authors: Husdal R, Toft E, Eriksson JW, et al.
Journal: BMC endocrine disorders, 2026 Jun 23
PMID: 42337478
DOI: 10.1186/s12902-026-02371-2
3. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Authors: Brown SA, Kovatchev BP, Raghinaru D, et al.
Journal: The New England journal of medicine, 2019 Oct 31
PMID: 31618560
DOI: 10.1056/NEJMoa1907863
4. Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
Authors: Marx N, Deanfield JE, Mann JFE, et al.
Journal: Circulation, 2025 Jun 10
PMID: 40156843
DOI: 10.1161/CIRCULATIONAHA.125.074545
5. Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Authors: Bruttomesso D, Petrie JR, Evans M, et al.
Journal: Diabetologia, 2026 Jun
PMID: 41820663
DOI: 10.1007/s00125-025-06651-9
6. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
Authors: Adler AI, Coleman RL, Leal J, et al.
Journal: Lancet (London, England), 2024 Jul 13
PMID: 38772405
DOI: 10.1016/S0140-6736(24)00537-3
7. Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.
Authors: Rosenstock J, Allison D, Birkenfeld AL, et al.
Journal: JAMA, 2019 Apr 16
PMID: 30903796
DOI: 10.1001/jama.2019.2942
8. A case report and literature review of proton pump inhibitors inducing insulin autoimmune syndrome.
Authors: Zhang W, Wen J, Qi S, et al.
Journal: Frontiers in endocrinology, 2026
PMID: 42318218
DOI: 10.3389/fendo.2026.1784299
Authors: Qi C, Mao X, Zhang Z, et al.
Journal: Journal of diabetes research, 2017
PMID: 28316995
DOI: 10.1155/2017/8637138
2. Virtual care for young adults with type 1 diabetes: a 12-month follow-up of a wait-list randomized controlled trial.
Authors: Husdal R, Toft E, Eriksson JW, et al.
Journal: BMC endocrine disorders, 2026 Jun 23
PMID: 42337478
DOI: 10.1186/s12902-026-02371-2
3. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Authors: Brown SA, Kovatchev BP, Raghinaru D, et al.
Journal: The New England journal of medicine, 2019 Oct 31
PMID: 31618560
DOI: 10.1056/NEJMoa1907863
4. Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
Authors: Marx N, Deanfield JE, Mann JFE, et al.
Journal: Circulation, 2025 Jun 10
PMID: 40156843
DOI: 10.1161/CIRCULATIONAHA.125.074545
5. Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Authors: Bruttomesso D, Petrie JR, Evans M, et al.
Journal: Diabetologia, 2026 Jun
PMID: 41820663
DOI: 10.1007/s00125-025-06651-9
6. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
Authors: Adler AI, Coleman RL, Leal J, et al.
Journal: Lancet (London, England), 2024 Jul 13
PMID: 38772405
DOI: 10.1016/S0140-6736(24)00537-3
7. Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.
Authors: Rosenstock J, Allison D, Birkenfeld AL, et al.
Journal: JAMA, 2019 Apr 16
PMID: 30903796
DOI: 10.1001/jama.2019.2942
8. A case report and literature review of proton pump inhibitors inducing insulin autoimmune syndrome.
Authors: Zhang W, Wen J, Qi S, et al.
Journal: Frontiers in endocrinology, 2026
PMID: 42318218
DOI: 10.3389/fendo.2026.1784299
